The Medicines Company To Present Data At On Infectious Disease Portfolio Including Recently Approved Antibiotic VABOMERE(Meropenem And Vaborbactam) Post author:Sam Post published:September 28, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Pfizer Backs and Inks $162M+ Deal With Tiny Adapsyn Bioscience January 8, 2018 Tetraphase's Lead Antibiotic Fails Another Late-Stage Study February 13, 2018 5 Big Pharmas Facing Catalysts in 2017 May 25, 2017